Bonita David P

SEC Form 4 insider trading activity

Bonita David P has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Apr 23, 2026.

On the most recent filing, Bonita David P is listed as Director, 10% Owner at Prelude Therapeutics Inc. Inside the rolling window, Bonita David P reported 1 open-market purchase totaling $12.5M in PRLD and no open-market sales.

Companies traded

Other insiders at PRLD

Insider Buying

$12.5M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
PRLD
Bonita David P
Purchase$12.5MApr 23SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Bonita David P made?

Bonita David P has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.

Which companies does Bonita David P trade?

Bonita David P has filed SEC Form 4 disclosures for 1 company, including PRLD.

When was Bonita David P's most recent SEC Form 4 filing?

Bonita David P's most recent SEC Form 4 filing on Tracefour is dated Apr 23, 2026.

What is Bonita David P's total buy and sell value in the current window?

Inside the rolling retention window, Bonita David P bought $12.5M and sold $0 based on SEC Form 4 filings.

What was Bonita David P's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 2,815,315 PRLD shares on 2026-04-21, worth $12.5M, per SEC Form 4 filings.